Kazuma Murakami

准教授 / Associate Professor

Kyoto University

Japan

Research Interests

Explore related searches

Professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Kazuma Murakami is an Associate Professor at Kyoto University, Japan. His research focuses on neurodegenerative diseases, particularly the role of amyloidogenic proteins and their interactions in protein aggregation. He has published extensively on topics such as the neurotoxic implications of human coronaviruses, the discovery of natural products for Alzheimer's therapeutics, and the development of inhibitors targeting amyloid β oligomerization.

Articles (12)

Year:

2025

Year:

2025

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Year:

JAPAN

View details

Kenjiro Ono

Kanazawa University Graduate School of Medical Sciences

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Kazuma Murakami

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

Lysine-Targeting Inhibitors of Amyloidogenic Protein Aggregation: A Promise for Neurodegenerative Proteinopathies

Neurotoxic Implications of Human Coronaviruses in Neurodegenerative Diseases: A Perspective from Amyloid Aggregation

Detection of Dietary Chalcone and Flavonoid Metabolites in Mice Using UPLC–MS/MS and Their Modulatory Effects on Amyloid β Aggregation

Synthetic Biology-Based Discovery of Diterpenoid Pyrones from the Genome of <i>Eupenicillium shearii</i>

Interactions of amyloid coaggregates with biomolecules and its relevance to neurodegeneration

Aptamers targeting amyloidogenic proteins and their emerging role in neurodegenerative diseases

Lysine-targeting inhibition of amyloid β oligomerization by a green perilla-derived metastable chalcone in vitro and in vivo

Searching for Natural Products That Delay Nucleation Phase and Promote Elongation Phase of Amyloid β42 toward Alzheimer’s Disease Therapeutics

Synthetic and Biophysical Studies on the Toxic Conformer in Amyloid β with the E22Δ Mutation in Alzheimer Pathology

Detection of Amyloid β Oligomers with RNA Aptamers in AppNL-G-F/NL-G-F Mice: A Model of Arctic Alzheimer’s Disease

Synthetic biology based construction of biological activity-related library of fungal decalin-containing diterpenoid pyrones

An RNA aptamer with potent affinity for a toxic dimer of amyloid β42 has potential utility for histochemical studies of Alzheimer's disease

Collaborators (6)

Yohei Morishita

Kenji Mizuguchi

Hideto Miyoshi

Kazuhiro Irie

Thi Hong Van NGUYEN

Kenjiro Ono

Make your next move.